DALESSANDRO, MARGHERITA
 Distribuzione geografica
Continente #
EU - Europa 336
NA - Nord America 325
AS - Asia 136
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 799
Nazione #
US - Stati Uniti d'America 325
UA - Ucraina 76
CN - Cina 59
IE - Irlanda 58
SE - Svezia 53
GB - Regno Unito 51
IT - Italia 39
TR - Turchia 39
IN - India 36
FR - Francia 30
DE - Germania 15
FI - Finlandia 13
EU - Europa 1
IL - Israele 1
IR - Iran 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 799
Città #
Chandler 97
Jacksonville 77
Dublin 58
Southend 50
Princeton 27
Izmir 26
Nanjing 23
Altamura 13
Cambridge 13
Pune 12
Wilmington 11
Ashburn 10
Boardman 10
Nanchang 9
Dearborn 8
Kunming 6
Hangzhou 4
Gela 3
Tianjin 3
Beijing 2
Bronte 2
Grevenbroich 2
Hebei 2
Jiaxing 2
Lanzhou 2
Messina 2
New York 2
Villarosa 2
Acireale 1
Adrano 1
Andover 1
Augusta 1
Caltanissetta 1
Changchun 1
Changsha 1
Chicago 1
Ficarra 1
Fuzhou 1
Leawood 1
Leicester 1
Los Angeles 1
Monmouth Junction 1
New Orleans 1
Ningbo 1
Norwalk 1
Piedimonte Etneo 1
Rio Saliceto 1
Seattle 1
Shenyang 1
Siracusa 1
Tappahannock 1
Wellington 1
Woodbridge 1
Totale 503
Nome #
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 96
Metabolic modifications in HIV-infected women 89
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 85
Acute urinary retention due to HSV-1: a case report 67
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 63
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 62
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 60
Interruption of highly active antiretroviral therpy in HIV clinical practice. 57
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 54
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 54
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 53
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 52
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 52
Totale 844
Categoria #
all - tutte 2.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 2 29
2019/2020153 53 12 5 3 13 6 17 12 2 12 17 1
2020/202182 13 0 15 0 14 14 3 0 3 13 4 3
2021/202251 1 1 0 3 10 0 1 6 1 2 9 17
2022/2023243 16 40 20 27 30 43 10 12 26 6 7 6
2023/202487 6 4 3 5 9 31 23 3 1 2 0 0
Totale 844